8-K: Abacus Life Reports Strong Q2 2024 Results with Revenue Doubling and Strategic Acquisitions

Sentiment:

Quarterly Report


Abacus Life announced a significant increase in revenue and profitability for the second quarter of 2024, alongside strategic acquisitions to expand its global presence.

Capital raiseAbacus completed a public equity offering that generated over $90 million in gross proceeds.The funds raised were used for new policy originations and other growth initiatives.
Better than expectedThe company's revenue more than doubled year-over-year, significantly exceeding expectations.Adjusted net income and adjusted EBITDA also showed substantial growth, indicating better-than-expected profitability.Policy originations and capital deployment increased significantly, demonstrating strong operational performance.

Summary

  • Abacus Life reported a substantial increase in revenue for the second quarter of 2024, more than doubling to $29.1 million compared to $11.4 million in the same period last year.
  • The company's net income was $0.8 million, while adjusted net income grew by 75% year-over-year to $11.8 million.
  • Adjusted EBITDA also saw significant growth, increasing by 83% year-over-year to $16.7 million.
  • Abacus deployed $104.7 million in origination capital, a notable increase from $59.8 million in the prior year, and policy originations grew by 95% to 275.
  • The company completed a public equity offering, raising over $90 million in gross proceeds, which were used for new policy originations and growth initiatives.
  • Abacus has also entered into agreements to acquire Carlisle Management and FCF Advisors, which are expected to add approximately $2.6 billion in assets under management.
  • As of June 30, 2024, Abacus had $91.3 million in cash and cash equivalents, $208.7 million in balance sheet policy assets, and $81.6 million in outstanding long-term debt.
  • The company repurchased approximately 1,048,000 shares of its common stock at an average price of $11.43, totaling $12 million, under its stock repurchase program.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the strong financial results, strategic acquisitions, and successful capital raise. The company's growth trajectory and management's confidence are evident.

Positives

  • Abacus Life demonstrated strong revenue growth, more than doubling year-over-year.
  • The company achieved significant growth in adjusted net income and adjusted EBITDA.
  • Policy originations and capital deployment saw substantial increases.
  • The successful public equity offering provided significant capital for growth initiatives.
  • Strategic acquisitions of Carlisle Management and FCF Advisors will expand the company's global reach and assets under management.
  • The company has a strong cash position of $91.3 million.

Negatives

  • U.S. GAAP net income decreased to $0.8 million, compared to $6.8 million in the prior year, primarily due to higher interest expense, non-cash stock compensation, and public company expenses.
  • Adjusted EBITDA margin decreased to 57.5% from 80.4% in the prior year.

Risks

  • The company's loss reserves are based on estimates and may be inadequate to cover actual losses.
  • Failure to properly price insurance policies could negatively impact results.
  • The company is subject to the cyclical nature of its industry.
  • Regulatory changes could impact the business.
  • Competition could affect the company's performance.
  • The company may not be able to raise capital on favorable terms or at all.
  • The company's control environment may have deficiencies.

Future Outlook

The company is focused on continued growth and profitability, with plans to integrate recent acquisitions and expand its lifespan-based financial product offerings. Abacus aims to solidify its position as a leading global market maker and alternative asset manager.

Management Comments

  • We delivered another excellent quarter, showcasing continued robust growth and profitability, as well as successfully executing on our long-term strategy, said Jay Jackson, Chief Executive Officer of Abacus.
  • These agreements underscore our relentless commitment to innovative solutions and long-term growth, and solidify Abacus as a leading global market maker and alternative asset manager.

Industry Context

This announcement highlights Abacus Life's strong position in the alternative asset management sector, particularly in the life settlements market. The acquisitions of Carlisle Management and FCF Advisors demonstrate a strategic move to expand globally and diversify product offerings, aligning with the trend of alternative asset managers seeking growth through acquisitions and international expansion.

Comparison to Industry Standards

  • Abacus Life's revenue growth of over 100% year-over-year significantly outpaces the average growth rate of many traditional asset managers, which typically see single-digit growth.
  • The adjusted EBITDA growth of 83% is also notably higher than the industry average, indicating strong operational efficiency and profitability.
  • Companies like GWG Holdings (prior to its bankruptcy) and Life Settlement Solutions also operate in the life settlement space, but Abacus's recent acquisitions and public equity offering position it as a more aggressive player in the market.
  • The annualized ROIC and ROE of 18% are competitive within the alternative asset management industry, where returns can vary widely based on investment strategies and market conditions.

Stakeholder Impact

  • Shareholders will benefit from the strong financial performance and strategic growth initiatives.
  • Employees may see increased opportunities due to the company's expansion.
  • Customers will have access to a broader range of financial products and services.
  • Suppliers and creditors will benefit from the company's financial stability and growth.

Next Steps

  • Abacus will integrate Carlisle Management and FCF Advisors into its operations.
  • The company will continue to deploy capital towards new policy originations and growth initiatives.
  • Abacus will continue to execute its stock repurchase program.
  • The company will host a webcast and conference call to discuss the results.

Key Dates

DateDescription
December 12, 2023Abacus announced a $15 million stock repurchase program.
June 30, 2024End of the second quarter, for which financial results are reported.
August 8, 2024Date through which Abacus has repurchased shares under the stock repurchase program.
August 12, 2024Date of the earnings release and 8-K filing.
June 10, 2025Expiration date of the stock repurchase program.

Keywords

life settlements, alternative asset management, longevity, actuarial technology, financial results, acquisitions, revenue growth, EBITDA, policy originations, capital deployment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.